Syngeneic Graft-vs-Host Disease

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

1985 • 600 citations

Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.

1978 • 524 citations

Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors.

1974 • 454 citations

Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease

1986 • 374 citations

Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution.

1983 • 285 citations

Gastrointestinal graft-versus-host disease in man

1979 • 251 citations

The skin biopsy in the diagnosis of acute graft-versus-host disease in man.

1977 • 237 citations

ACUTE GRAFT-VERSUS-HOST DISEASE IN RECIPIENTS OF BONE-MARROW TRANSPLANTS FROM IDENTICAL TWIN DONORS

1979 • 134 citations

Destruction of autologous human lymphocytes by interleukin 2-activated cytotoxic cells.

1986 • 116 citations

Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones.

1986 • 105 citations

Prevention of lethal, minor-determinate graft-host disease in mice by the in vivo administration of anti-asialo GM1.

1983 • 54 citations

Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model. Evidence that large granular lymphocytes are effector cells in the immune response.

1986 • 51 citations

Cited By (0)

Loading...